BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioMidwest

  Bridge to Life Ltd. Announces First Enrollment and Orthotopic Liver Transplantation in its Pivotal Bridge to HOPE Liver Clinical Trial

  Bridge to Life Ltd. announced first enrollment and orthotopic liver transplantation in its U.S. pivotal Bridge to HOPE Liver Clinical Trial (NCT05045794).

  February 2, 2022

   · 

  4 min read
• BioMidwest

  American Cancer Society and Sleep Number Partner to Study Impact of Quality Sleep on Cancer Prevention and Survivorship

  The American Cancer Society and Sleep Number Corporation announce a landmark partnership to embark upon foundational sleep research to inform the first-ever sleep guidelines for cancer.

  February 2, 2022

   · 

  3 min read
• BioMidwest

  Edgewise Therapeutics to Participate at SVB Leerink 11th Annual Global Healthcare Conference on February 16

  Edgewise Therapeutics, Inc. announced that members of its senior management team will participate in a fireside discussion and one-on-one investor meetings at the SVB Leerink Virtual 11th Annual Global Healthcare Conference, on February 16, 2022.

  February 2, 2022

   · 

  1 min read
• Deals

  Fagron strengthens position in US with acquisition of Letco and divestment of non-core activities

  Fagron, the world leader in pharmaceutical compounding, announced it has reached an agreement to acquire Letco Medical.

  February 2, 2022

   · 

  4 min read
• Business

  Lykan Bioscience Welcomes Jay Blackington as Head of People and Culture

  Lykan Bioscience today welcomes Jay Blackington as Head of People and Culture.

  February 2, 2022

   · 

  2 min read
• Hemostemix Announces Financing

  The Offering will consist of the issuance of an aggregate of up to 7,200,000 Units at a price of $0.14 per Unit.

  February 2, 2022

   · 

  9 min read
• Biotech Bay

  Adicet Bio to Participate in Guggenheim 2022 Oncology Conference

  Adicet Bio, Inc. announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2022 Oncology Conference taking place virtually on February 9-11, 2022.

  February 2, 2022

   · 

  1 min read
• Business

  Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022

  Venus Concept Inc. announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March 28, 2022.

  February 2, 2022

   · 

  1 min read
• Biotech Beach

  Turning Point Therapeutics to Participate in Upcoming Investor Conferences - Feb 02, 2022

  Turning Point Therapeutics, Inc. announced that President and CEO Athena Countouriotis, M.D., will participate in the Guggenheim Healthcare Talks 2022 Oncology Day on February 9 and the 11th Annual SVB Leerink Global Healthcare Conference on February 16.

  February 2, 2022

   · 

  3 min read
• BioMidwest

  Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time

  Accelerate Diagnostics, Inc. announced that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time.

  February 2, 2022

   · 

  1 min read